A Propensity-Matched Cohort Study of Tocilizumab in Patients With Coronavirus Disease 2019

To determine the impact of tocilizumab, a monoclonal antibody against the interleukin 6 receptor, on survival in patients with coronavirus disease 2019. DESIGN: Observational cohort study of patients hospitalized with coronavirus disease 2019 between March 1, 2020, and April 24, 2020. A propensity-m...

Descripción completa

Detalles Bibliográficos
Autores principales: Lewis, Tyler C., Adhikari, Samrachana, Tatapudi, Vasishta, Holub, Meredith, Kunichoff, Dennis, Troxel, Andrea B., Montgomery, Robert A., Sterman, Daniel H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Original Clinical Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7671881/
https://www.ncbi.nlm.nih.gov/pubmed/33225307
http://dx.doi.org/10.1097/CCE.0000000000000283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7671881/
https://www.ncbi.nlm.nih.gov/pubmed/33225307
http://dx.doi.org/10.1097/CCE.0000000000000283

Ejemplares similares